the Global Drug Facility operates a direct procurement system to achieve competitive prices for anti-tuberculosis drugs that meet WHO’s stringent standards, and provides in-country assistance on supply chain management.
Similarly, the Green Light Committee was established to improve access to high-quality second-line anti-tuberculosis drugs for MDR tuberculosis at reduced prices, and to assist countries in programmatic management of MDR tuberculosis.